Clinical Trial Update: Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates whether adding radiotherapy to nivolumab can produce abscopal anti-tumor effects in relapsed classical Hodgkin lymphoma after prior an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: University of Cologne | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING